标题
Controversies and challenges regarding the impact of radiation therapy on survival
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 24, Issue 1, Pages 38-46
出版商
Oxford University Press (OUP)
发表日期
2012-08-17
DOI
10.1093/annonc/mds217
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- TFAP2E–DKK4and Chemoresistance in Colorectal Cancer
- (2012) Matthias P.A. Ebert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer Decreases Distant Recurrence and Could Eradicate Local Recurrence
- (2011) Luiz Felipe de Campos-Lobato et al. ANNALS OF SURGICAL ONCOLOGY
- Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer
- (2011) P. P. Grimminger et al. CLINICAL CANCER RESEARCH
- DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non–Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy
- (2011) Li-E Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy
- (2011) Vicki Leigh Keedy et al. JOURNAL OF CLINICAL ONCOLOGY
- Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
- (2011) Patrick J. Loehrer et al. JOURNAL OF CLINICAL ONCOLOGY
- Magnetic Resonance Imaging–Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience
- (2011) Uday B. Patel et al. JOURNAL OF CLINICAL ONCOLOGY
- Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
- (2011) Christopher M Nutting et al. LANCET ONCOLOGY
- PET scans in radiotherapy planning of lung cancer
- (2011) Dirk De Ruysscher et al. LUNG CANCER
- The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT)
- (2011) Atsuya Takeda et al. RADIOTHERAPY AND ONCOLOGY
- Cetuximab and chemoradiation for rectal cancer–is the water getting muddy?
- (2010) Rob Glynne-Jones et al. ACTA ONCOLOGICA
- Altered fractionation in radiotherapy: From radiobiological rationale to therapeutic gain
- (2010) Loredana G. Marcu CANCER TREATMENT REVIEWS
- The role of hypoxia inducible factor-1alpha in gynecological cancer
- (2010) Laura M.S. Seeber et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma
- (2010) Nobuyuki Kawai et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- KRAS and BRAF Mutations and PTEN Expression Do Not Predict Efficacy of Cetuximab-Based Chemoradiotherapy in Locally Advanced Rectal Cancer
- (2010) Philipp Erben et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiosensitizing Drugs: Lessons to Be Learned From the Oxaliplatin Story
- (2010) Kjersti Flatmark et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of DNA Repair Gene Polymorphisms With Response to Platinum-Based Doublet Chemotherapy in Patients With Non–Small-Cell Lung Cancer
- (2010) Kouya Shiraishi et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
- (2010) Anne Aupérin et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemoradiotherapy and Gefitinib in Stage III Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor and KRAS Mutation Analysis: Cancer and Leukemia Group B (CALEB) 30106, a CALGB-Stratified Phase II Trial
- (2010) Neal Ready et al. Journal of Thoracic Oncology
- Animal testing alternatives come alive in US
- (2010) Elie Dolgin NATURE MEDICINE
- Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials
- (2009) Gustavo Arruda Viani et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
- (2009) Christine A. Iacobuzio-Donahue et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Biomarkers of response and resistance to antiangiogenic therapy
- (2009) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
- (2009) Jean-Pierre Pignon et al. RADIOTHERAPY AND ONCOLOGY
- Molecular Advances of Brain Tumors in Radiation Oncology
- (2009) Shin-ei Noda et al. SEMINARS IN RADIATION ONCOLOGY
- Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study
- (2008) B. Chauffert et al. ANNALS OF ONCOLOGY
- Preoperative chemoradiationversusradiation alone for stage II and III resectable rectal cancer: A systematic review and meta-analysis
- (2008) Wim Ceelen et al. INTERNATIONAL JOURNAL OF CANCER
- Wild-TypeBRAFIs Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
- (2008) Federica Di Nicolantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials
- (2008) JOURNAL OF CLINICAL ONCOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- The use of xenograft models for the selection of cancer treatments with the EGFR as an example
- (2007) Teresa Troiani et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search